At the last annual meeting of the Academy of Managed Care Pharmacy, several of us spoke on pharmaceutical research and development in the quickly emerging value-driven healthcare system. Topics focused on the impact of value-based benefit designs, comparative effectiveness research, and government policies on the development of new drugs and biologics:

Research and Development in the Current Healthcare System: An Overview

Thomas McCarter, MD, FACP

What Constitutes Medical Evidence in the Era of Comparative Effectiveness?

Nirav R. Shah, MD, MPH, FACP

New Government Policies: Opportunities for Supporting Research and Development

Kip Piper, MA, FACHE

Drug Discovery and Development in a Value-Driven Healthcare System

Matthew Sarnes, PharmD

A Hypothetical Case: Current Drug R&D Process

Michael F. Murphy, MD, PhD

Our presentations were published in a supplement issue of American Health & Drug Benefits, a peer-reviewed journal serving about 30,000 decision makers. To read the articles, which are approved for continuing education credit, click here.